Safety Reporting
Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.
4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.
The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.
The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.
4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.
4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).
Clinical Research News
Bevorstehende klinische Studien
-
Zheng LiNoch keine RekrutierungKognitive Gebrechlichkeit
-
Techpool Bio-Pharma Co., Ltd.Noch keine Rekrutierung
-
Istanbul University - CerrahpasaRekrutierungZerebralpareseTürkei (türkiye)
-
Project Skin MDNoch keine Rekrutierung
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Noch keine RekrutierungAkuter ischämischer Schlaganfall AIS
-
Hospital Universitario La PazNoch keine RekrutierungNasale Obstruktion | Bronchiolitis | Akute Infektionen der oberen AtemwegeSpanien
-
E-DA HospitalNational Cheng Kung University; Metal Industries Research & Development Centre...RekrutierungObstruktive SchlafapnoeTaiwan
-
Assistance Publique - Hôpitaux de ParisNoch keine RekrutierungKomplikation der extrakorporalen Membranoxygenierung | ECMO Cannula InfectionFrankreich
-
Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd.RekrutierungBrustkrebs | Magenkrebs | Eierstockkrebs | Fortgeschrittene solide Tumoren | Andere solide TumorenChina
-
Gustave Roussy, Cancer Campus, Grand ParisNoch keine RekrutierungAdult Carriers of a Pathogenic or Probably Pathogenic (Class 4 and 5) Germline Variation in the TP53 GeneFrankreich
-
Assistance Publique - Hôpitaux de ParisRekrutierungAufmerksamkeitsdefizitsyndromFrankreich
-
University GhentNoch keine RekrutierungPostoperativer Schmerz, akut | Irreversible Pulpitis (Zahnschmerzen) | Pulp Necrosis, Apical PeriodontitisBelgien
Clinical Research Jobs
-
Italy - Milan
-
United States - Shrewsbury
-
United Kingdom - Leeds
-
India - Kochi
-
United States - Massachusetts - Boston
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China